Clinical trial Recruiting at 1 site Interventional

Genetic diagnosis and personalized medicine for epilepsy patients

Official title: Characterization of Patients With Epilepsy With an Integrated Approach of Clinical, Neurophysiological, Neuroradiological, Neuropsychological and Laboratory (Exome) Methods for Personalized Medicine

Run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06321822 · Data updated 2026-11-12

This study is testing if looking at the genes of people with epilepsy can help doctors find better, personalized treatments for them.

Quick facts

Study typeInterventional
SexAll
Enrollment500 (estimated)
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedAugust 2, 2021
Main results expectedAugust 2, 2025
Study endsDecember 31, 2026
Registry record updatedMarch 20, 2024
Trial IDNCT06321822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include both minors and adults diagnosed with epilepsy who are being followed at the participating epilepsy clinics.

Probably not a fit

Patients with epilepsy who do not have available DNA samples from themselves and both parents may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the genetic causes of epilepsy by collecting clinical and instrumental data from patients at their first outpatient visit and one year later. It focuses on patients diagnosed with epilepsy, utilizing whole exome sequencing (WES) to identify potential genetic mutations. The study will also analyze the relationship between genotype and phenotype to improve personalized treatment approaches. Data will be gathered from both patients and their parents to enhance the understanding of hereditary factors in epilepsy.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and personalized treatment plans for patients with epilepsy.

How similar studies have gone: Other studies utilizing genetic sequencing for epilepsy have shown promise, indicating that this approach could be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Study population: patients with epilepsy.

Patients who meet all of the following criteria will be included:

* Patients both minors and adults diagnosed with epilepsy;
* of both sexes;
* followed at the pediatric and adult epilepsy and electroencephalography clinics of the U.O.C. Neurophysiopathology - IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico;
* Informed consent of the patient if an adult and capable of providing consent independently or of the parents or legal guardians in the case of a minor/individual not capable of providing consent independently.

Inclusion criteria for exome candidate patients:

* Availability of DNA samples from the patient and both natural parents;
* Prediction of high positive genetic diagnosis Patients diagnosed with epilepsy will be recruited among those followed at the pediatric and adult epilepsy and electroencephalography clinics of the U.O.C. Neurophysiopathology - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, after signing the consent.

Exclusion Criteria:

* Patients who possess at least one of the following criteria will be excluded:
* Patients arriving for evaluation with the initial suspicion of epilepsy who during the diagnostic work-up were found to be suffering from a different pathology;
* Patients who have refused consent to participate in the study.

Where it's running

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.